Top stories you may have missed

Here are some of the articles MedBrief Africa readers found the most interesting in the past week

Medical schemes not up to members’ expectations, survey shows

Medical schemes are facing tremendous pressure in a low growth market where customer expectations and utilisation are very high and increasing, while loyalty is...

Harnessing Africa’s potential to develop medicines for its people

The director and founder of the University of Cape Town’s world renowned Drug Discovery and Development Centre, H3D, Prof Kelly Chibale, is on a drive to highlight...

Acino signs R3bn acquisition deal with Takeda

Swiss-based pharmaceutical company Acino and Takeda Pharmaceuticals have signed an agreement for Acino to acquire parts of Takeda’s primary care portfolio in Africa, the Middle East...

World Menopause Day: Many women still suffering in silence

It is estimated that by 2030 1.2 billion women will either be menopausal or postmenopausal, yet social attitudes towards women in menopause is often...

Next week’s ISQua conference timely for SA

The International Society for Quality in Health Care (ISQua), in partnership with The Council for Health Service Accreditation of Southern Africa (COHSASA) and Mediclinic...

Local study sheds new light on barriers to HIV cure

An international, collaborative study led by University of Cape Town (UCT) researchers has revealed an unexpected finding that could lead to better therapies towards...

Work needed ‘to restore faith in Health Technology Assessment (HTA)’

The generally negative perceptions of Health Technology Assessment (HTA) processes in South Africa largely due to the fragmented nature of their implementation and to...

Extended hormone therapy associated with improved cognition

A new study published in Menopause, the journal of The North American Menopause Society (NAMS) demonstrates the benefits of extended oestrogen exposure and longer-term...

Medipost saves R157m on medicine costs

Courier pharmacy company, Medipost Holdings has saved the South African healthcare industry over R157 million on medicine costs since its establishment a year ago.  “These...

Health Funders Association supportive of HMI recommendations

The Health Funders Association (HFA) has welcomed recommendations for the transformation of the funding industry contained in the Health Market Inquiry’s (HMI) final report...

Drug reverses signs of NAFLD in people with HIV

Researchers at the National Institutes of Health and their colleagues at Massachusetts General Hospital (MGH) in Boston report that the injectable hormone, tesamorelin reduces...

CMS Annual Report: Financial health of schemes and members declining as...

Findings of the Health Market Inquiry on increasing healthcare costs in the private sector and its recommendations for far-reaching changes to the current status...

State’s right of recovery against its Doctors

Part 2 (Continued from Part 1: Med Brief Africa 8 October 2019) A Province would be vicariously liable for harm caused by the negligent conduct of...

Aggressive HbA1c lowering in T1DM does not reduce eye, kidney disease

A glycated hemoglobin (HbA1c) target value of <6.5 percent does not offer additional protection against organ complications for patients with type 1 diabetes compared with a target...

State’s right of recovery against its Doctors

Part 1* As a general rule an employer, such as a private hospital or, the Province, in the case of a state health facility, is liable...

Monitoring BP medication compliance does not improve control

Interactive interventions to improve medication adherence do not improve blood pressure (BP) control, a study recently published in the Journal of General Internal Medicine has...

Top stories you may have missed

Here are some of the articles MedBrief Africa readers found the most interesting in the past week